Report overview
The global Blood Vessels Embolic Agents market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
Playing a more vital role in the field of medicine than ever before, embolotherapy is a type of endovascular treatment that aims to occlude abnormal blood vessels in order to control bleeding, close fistulae or arteriovenous malformations, devascularise organs, reduce tumours and much more. This report focus on Blood Vessels Embolic Agents market.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
We have surveyed the Blood Vessels Embolic Agents companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Blood Vessels Embolic Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Vessels Embolic Agents. This report contains market size and forecasts of Blood Vessels Embolic Agents in global, including the following market information:
Global Blood Vessels Embolic Agents market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Blood Vessels Embolic Agents companies in 2024 (%)
Total Market by Segment:
Global Blood Vessels Embolic Agents market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Blood Vessels Embolic Agents market segment percentages, by Type, 2024 (%)
Microsphere
Liquid Embolics Agents
Embolic Coils
Embolic Plug Systems
Detachable Balloons
Others
Global Blood Vessels Embolic Agents market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Blood Vessels Embolic Agents market segment percentages, by Application, 2024 (%)
Hospital & Clinic
Ambulatory Surgical Center
Others
Global Blood Vessels Embolic Agents market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Blood Vessels Embolic Agents market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Blood Vessels Embolic Agents revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Blood Vessels Embolic Agents revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Boston Scientific Corporation
Cook Medical LLC
Johnson & Johnson
Medtronic
Acandis GmbH
SSEM Mthembu Medical (Pty) Ltd
Balt USA LLC
Stryker
Guerbet LLC
Terumo Corporation
Penumbra
Grandpharma (Sirtex)
Merit Medical
Siemens Healthineers (Varian)
Jiangsu Hengrui Medicine
Kaneka
Meril Life Sciences
Peijia Medical
Wallaby Medical
MicroPort Scientific Corporation
Weihai Visee Medical Devices
Beijing Taijieweiye Technology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Blood Vessels Embolic Agents, market overview.
Chapter 2: Global Blood Vessels Embolic Agents market size in revenue.
Chapter 3: Detailed analysis of Blood Vessels Embolic Agents company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Blood Vessels Embolic Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
